DUBLIN–(BUSINESS WIRE)–The “Contraceptives Market Analysis by Product (Topical, Oral Contraceptive Pills, Injectable Contraceptives), by Device (Male Condoms, Diaphragms, Female Condoms, Vaginal Rings, Sub Dermal Implants, Intra-Uterine Devices), and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.
The global contraceptives market size is estimated to be USD 23.52 billion in 2021 and is expected to witness a CAGR of 6.31% during the forecast period.
Companies Mentioned
- The Female Health Company (U.K.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Reckitt Benckiser Plc (U.K.)
- Pfizer Inc. (U.S.)
- Mayer Laboratories Inc. (U.S.)
- Cooper Surgical (U.S.)
- Church & Dwight Co. Inc. (U.S.)
- Actavis plc (U.S.)
- Merck & Co. (U.S.)
- Ansell Limited (Australia)
NGO and government initiatives to encourage use of contraceptive methods is a key driver for the growth of the global contraceptives market. Additionally, rising need for checking unwanted pregnancy and increase in awareness about contraceptives worldwide are some of the other drivers propelling the market growth. Nevertheless, health risks related with the usage of various contraceptive methods and rapid growth in aging population and rise in cases of infertility are expected to restrain the global market growth.
Key Topics Covered:
1. Research Methodology
2. Introduction: Contraceptives
3. Executive Summary
3.1.Global Market Scenario
3.2.Segment Market Scenario
3.3.Geographic Market Scenario
3.4.COVID-19 Impact
3.5.Competitive Landscape
4. Market Dynamics
5. Market Environment Analysis
5.1.Porter’s 5 Forces Analysis
5.2.PESTEL Analysis
5.3.Value Chain Analysis
5.4.SWOT Analysis
5.5.Benchmark
6. COVID-19 Impact Analysis: Contraceptives Market
6.1.COVID-19: Overview
6.2.COVID-19 Impact on the Global Market
6.3.COVID-19 Impact on the Regional Markets
7. Market Analysis by Product
7.1.Topical contraceptives
7.1.1.Topical contraceptives Market Forecast, 2021-2029 (USD Million)
7.2.Oral contraceptive pills
7.2.1.Oral contraceptive pills Market Forecast, 2021-2029 (USD Million)
7.3.Injectable contraceptives
7.3.1.Injectable contraceptives Market Forecast, 2021-2029 (USD Million)
8. Market Analysis by Device
8.1.Contraceptive sponges
8.1.1.Contraceptive sponges Market Forecast, 2021-2029 (USD Million)
8.2.Male condoms
8.2.1.Male condoms Market Forecast, 2021-2029 (USD Million)
8.3.Diaphragms
8.3.1.Diaphragms Market Forecast, 2021-2029 (USD Million)
8.4.Female condoms
8.4.1.Female condoms Market Forecast, 2021-2029 (USD Million)
8.5.Vaginal rings
8.5.1.Vaginal rings Market Forecast, 2021-2029 (USD Million)
8.6.Subdermal implants
8.6.1.Subdermal implants Market Forecast, 2021-2029 (USD Million)
8.7.Intra-uterine devices
8.7.1.Intra-uterine devices Market Forecast, 2021-2029 (USD Million)
9. Regional Market Analysis
9.1.Regional Market Trends
9.2.Regional Market: Comparative Analysis
10. North America Contraceptives Market
11. Europe Contraceptives Market
12. Asia Pacific Contraceptives Market
13. Latin America Contraceptives Market
14. MEA Contraceptives Market
15. Competitor Analysis
15.1.Market Share Analysis, 2021 & 2029
15.2.Competitive Mapping
15.3.Key Players Market Place Analysis
15.4.Major Recent Developments
16. Company Profiles
16.1.The Female Health Company (U.K.)
16.1.1.Company Snapshot
16.1.2.Company Overview
16.1.3.Financials
16.1.4.Product Benchmarking
16.1.5.Recent Developments
16.2.Teva Pharmaceutical Industries Ltd. (Israel)
16.2.1.Company Snapshot
16.2.2.Company Overview
16.2.3.Financials
16.2.4.Product Benchmarking
16.2.5.Recent Developments
16.3.Pfizer, Inc. (U.S.)
16.3.1.Company Snapshot
16.3.2.Company Overview
16.3.3.Financials
16.3.4.Product Benchmarking
16.3.5.Recent Developments
16.4.Mayer Laboratories, Inc. (U.S.)
16.4.1.Company Snapshot
16.4.2.Company Overview
16.4.3.Financials
16.4.4.Product Benchmarking
16.4.5.Recent Developments
16.5.Cooper Surgical (U.S.)
16.5.1.Company Snapshot
16.5.2.Company Overview
16.5.3.Financials
16.5.4.Product Benchmarking
16.5.5.Recent Developments
16.6.Church & Dwight Co. Inc. (U.S.)
16.6.1.Company Snapshot
16.6.2.Company Overview
16.6.3.Financials
16.6.4.Product Benchmarking
16.6.5.Recent Developments
16.7.Actavis plc (U.S.)
16.7.1.Company Snapshot
16.7.2.Company Overview
16.7.3.Financials
16.7.4.Product Benchmarking
16.7.5.Recent Developments
16.8.Merck & Co. (U.S.)
16.8.1.Company Snapshot
16.8.2.Company Overview
16.8.3.Financials
16.8.4.Product Benchmarking
16.8.5.Recent Developments
16.9.Ansell Limited (Australia)
16.9.1.Company Snapshot
16.9.2.Company Overview
16.9.3.Financials
16.9.4.Product Benchmarking
16.9.5.Recent Developments
16.10.Dilon Technologies, Inc. (US)
16.10.1.Company Snapshot
16.10.2.Company Overview
16.10.3.Financials
16.10.4.Product Benchmarking
16.10.5.Recent Developments
16.11.Planmed Oy (Finland)
16.11.1.Company Snapshot
16.11.2.Company Overview
16.11.3.Financials
16.11.4.Product Benchmarking
16.11.5.Recent Developments
16.12.Delphinus Medical Technologies, Inc. (US)
16.12.1.Company Snapshot
16.12.2.Company Overview
16.12.3.Financials
16.12.4.Product Benchmarking
16.12.5.Recent Developments
17.Conclusion & Recommendations
For more information about this report visit https://www.researchandmarkets.com/r/eioyj9
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900